Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy

##plugins.themes.academic_pro.article.sidebar##

Published Dec 23, 2015
Download
pdf
Vol. 93 No. 10 (2015): Issue Oct 2015

##plugins.themes.academic_pro.article.main##

Dalila Gargouri
Service de Gastro-entérologie Hôpital H. Thameur Tunis
Asma Ouakaa-Kchaou
Service de Gastro-entérologie Hôpital H. Thameur Tunis
Asma Kochlef
Héla Elloumi
Norsaf Bibani
Dorra Trad
Mohamed Zili
Jamel Kharrat

Abstract

SUMMARY
Background: Biliary obstruction together with bacterial colonization of the bile duct may lead to development of acute cholangitis. The reported incidence of infectious complications may reach up to 10%. Nevertheless, no antibiotic prophylaxis is administered routinely, prior to endoscopic therapeutic procedures.
Aim: To investigate the presence and degree of biliary bacterial colonization during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary obstruction. Furthermore, we evaluated antibiotic therapy regimens, which would cover the bacterial species obtained by ERCP and subsequent culture in each patient.
Methods: Forty-four patients with biliary obstruction who underwent an ERCP with biliary drainage were prospectively included. The primary indication of ERCP was choledocholithiasis (48%), followed by benign biliary strictures (32%) and malignant bile duct obstruction (18%). Bile cultures were obtained by means of bile
aspiration via the cannulation catheter. Aerobic and anaerobic cultures were prepared from all obtained specimens and the isolated organisms were identified. In the case of positive cultures, an in-vitro resistance test for different antibiotics was performed.
Results: The overall positive rate of bile culture was 93%. The organisms cultured were Escherichia coli (26.8%), Enterococcus (17%), Klebsiella (14.6%), Enterobacter (14.6%) and Pseudomonas (9.7%) in decreasing order. In-vitro testing of different antibiotics was carried out in these 41 isolates. Imipenem showed the best antimicrobial activity (sensitivity, 100%), followed by colistin (94%), tobramycin (93%), amikacin (89.6%), gentamycin (85.2%) and ceftazidin (82%). Amoxicillin/clavulanic acid and ofloxacin were less sensitive (66% and 60% respectively). Ceftazidin was the most effective antibiotic on Escherichia coli (sensitivity 83%). Multi-resistant organisms were noted in 22% of the cases.

Conclusions: Escherichia coli was found to be the pathogen most frequently detected in bile following endoscopic interventions in the biliary tract. Enterococci and Klebsiella were found in bile cultures with an incidence exceeding 10%. In view of the in-vitro test results, amoxicillin/clavulanic acid or quinolons are not suitable antibiotics for the prophylaxis of biliary infections. Moreover, Gram-positive bacteria such as Enterococcus are emerging as causative microorganisms. If these organisms are isolated, antimicrobial drugs should be replaced by narrower-spectrum antimicrobials.

Keywords:

Bile culture, microbiology, antimicrobial susceptibility, endoscopic retrograde cholangiopancreatography, choledocholithiasis, biliary stent

##plugins.themes.academic_pro.article.details##

References

  1. Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Therap 1999;13:103-16
  2. Herzog T, Belyaev O, Muller CA, Mittelkotter U, Seelig MH, Weyhe D. Bacteribilia after preoperative bile duct stenting: a prospective study. J Clin Gastroenterol 2009; 43:457-62
  3. Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R. Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance. Z Gastroenterol 2001;39:985-92.
  4. Lorenz R, Herrmann M, Kassem AM, Lehn N, Neuhaus H, Classen M. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system. Endoscopy 1998;30:708- 12.
  5. Misra V, Misra SP, Singh PA, Dwivedi M, Verma K, Narayan U. Significance of cytomorphological and microbiological examination of bile collected by endoscopic cannulation of the papilla of vater. Indian J Pathol Microbiol 2009;52:328-31.
  6. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002;56:885- 9.
  7. Won Ki B, Young Soo M, Jong Hoon K, Seuk Hyun L. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol 2008;51:248-54.
  8. DemirbaÄŸ AE, Karademir A, Parlak E, Sen S, Karahan M, Kayaalp C, Sahin B. Multidrug resistance of isolated microorganisms in occluded bile duct stents. Turk J Gastroenterol 2007;18:33-40.
  9. Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010;72:284-91.
  10. Millonig G, Buratti T, I Graziadei W, Schwaighofer H, Orth D, Margreiter R, Vogel W. Bactobilia after liver transplantation: Frequency and antibiotic susceptibility. Liv Transp 2006;12:747-53
  11. Bai Y, Gao F, Gao J, Zou DW, Li ZS. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography induced cholangitis: a meta-analysis. Pancreas 2009;38:126-30.
  12. Byl B, Deviere J, Struelens MJ, Roucloux I, De Coninck A, Thys JP. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: A randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995;20:1236-40.
  13. Brand M, Bizos D, O'Farrell PJR. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database of Systematic Reviews 2010.
  14. Ceyssens C, Frans JM, Christiaens PS, Van Steenbergen W, Peetermans WE. Recommendations for antibiotic prophylaxis before ERCP: can we come to workable conclusions after review of the literature? Acta Clin Belg 2006;61:10-8.
  15. Harris A, Chan AC, Torres-Viera C, Hammett R, Carr-Locke D. Metaanalysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31:718-24.
  16. Kolios D, Alveyn G, Robertson CG. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 1998;12:207- 11.
  17. Llach J, Bordas JM, Almela M, Pellise M, Mata A, Soria M. Prospective assessment of the role of antibiotic prophylaxis in ERCP. Hepatogastroenterol 2006; 53:540-2.
  18. Niederau C, Pohlmann U, Lubke H, Lutz T. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 1994;40:533- 7.
  19. Sauter G, Grabein B, Mannes GA, Ruckdeschel G, Sauerbruch T. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990;22:164-7.
  20. Spicak J, Stirand P, Zavoral M, Keil R, Zavada F, Drabek J. Antibiotic prophylaxis of cholangitis complicating endoscopic management of biliary obstruction. Gastrointest Endosc 2000;55:AB157.
  21. Van den Hazel SJ, Speelman P, Dankert J, Huibregtse K, Tytgat GNJ, Van Leeuwen DJ. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Inter Med 1996;125:442-7.
  22. Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost? Aliment Pharmacol Ther 2002;16:727-34.